Specialty: Regulatory Affairs Consulting

Dr. Darius Devlin is an interdisciplinary molecular biologist and regulatory professional passionate about novel treatments and therapies for diseases/conditions with limited options.

He was previously a laboratory scientist with expertise in reproductive biology/infertility, molecular cloning, recombinant protein expression/purification, mouse model generation, and preclinical testing of therapeutic agents.

Now Dr. Darius’ regulatory experience includes successful track record with orphan drug designation (ODD) application, investigational new drug (IND), development safety update report (DSUR), and ODD annual report submissions.